InnoCare Pharma Ltd banner

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 27.09 CNY 7.08% Market Closed
Market Cap: ¥22.9B

Wall Street
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 34.76 CNY with a low forecast of 33.58 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
33.58 CNY
24% Upside
Average
Price Target
34.76 CNY
28% Upside
Highest
Price Target
36.75 CNY
36% Upside
InnoCare Pharma Ltd Competitors:
Price Targets
ADSK
Autodesk Inc
42% Upside
STG
Strip Tinning Holdings PLC
137% Upside
CDNA
CareDx Inc
56% Upside
8841
TOC Co Ltd
37% Upside

Revenue
Forecast

23% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
23% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

For the last 4 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is 23%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

N/A
Past Growth
-67% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
-67% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of InnoCare Pharma Ltd's net income for the next 2 years is -67%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InnoCare Pharma Ltd's stock price target?
Price Target
34.76 CNY

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 34.76 CNY with a low forecast of 33.58 CNY and a high forecast of 36.75 CNY.

What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
12%

For the last 4 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is 23%. The projected CAGR for the next 3 years is 12%.

What is InnoCare Pharma Ltd's Net Income forecast?
Projected CAGR
-67%

The compound annual growth rate of InnoCare Pharma Ltd's net income for the next 2 years is -67%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett